title: Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus.
authors.affiliation: Stanford University School of Medicine, Stanford, California, USA.
authors.forename: F
authors.initials: F
authors.lastname: Abbasi
authors.forename: T
authors.initials: T
authors.lastname: Asagmi
authors.forename: J P
authors.initials: JP
authors.lastname: Cooke
authors.forename: C
authors.initials: C
authors.lastname: Lamendola
authors.forename: T
authors.initials: T
authors.lastname: McLaughlin
authors.forename: G M
authors.initials: GM
authors.lastname: Reaven
authors.forename: M
authors.initials: M
authors.lastname: Stuehlinger
authors.forename: P S
authors.initials: PS
authors.lastname: Tsao
mesh_terms: D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood*; D001786:Blood Glucose; D016022:Case-Control Studies; D002784:Cholesterol / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D004791:Enzyme Inhibitors / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors
chemical_list: D001786:Blood Glucose; D004791:Enzyme Inhibitors; C018524:N,N-dimethylarginine; D001120:Arginine; D002784:Cholesterol; D019001:Nitric Oxide Synthase